bioAffinity Technologies, Inc.(BIAF)

Medical - Diagnostics & Research · San Antonio, TX

$6.18-0.01 (-0.16%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T14:11:01.880Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:11:01.880Z.

Quote observation: 2026-10-06T14:10:22.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 2,588,623
Total debt · period ending 2026-06-30: 1,435,005
Cash · period ending 2026-06-30: 2,429,719
TTM operating EBITDA · period ending 2026-06-30: -11,968,556

FMP input reference: b8a0cb47064437e8b9c77c3ec53eeb060705b9d611480c07f1c1fa4a72564033

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BIAF EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

BIAF Competitors' EV/EBITDA Ratio

BIAF

bioAffinity Technologies, Inc.

Current

Market Cap

$2.59M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ISPC

iSpecimen Inc.

vs BIAF

Market Cap

$2.60M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JAGX

Jaguar Health, Inc.

vs BIAF

Market Cap

$2.76M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBRX

Moleculin Biotech, Inc.

vs BIAF

Market Cap

$2.51M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBLG

FibroBiologics, Inc. Common Stock

vs BIAF

Market Cap

$2.43M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ITOC

iTonic Holdings Ltd.

vs BIAF

Market Cap

$2.38M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs BIAF

Market Cap

$2.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BRTX

BioRestorative Therapies, Inc.

vs BIAF

Market Cap

$3.18M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADGM

Adagio Medical Holdings, Inc.

vs BIAF

Market Cap

$3.13M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs BIAF

Market Cap

$2.07M

EV/EBITDA Ratio

N/A

TTM Avg

10388992794.84x

3Y Avg

12435877641.77x

5Y Avg

12435877641.77x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
bioAffinity Technologies, Inc. (BIAF)	$2.59M	N/A	N/A	N/A	N/A
iSpecimen Inc. (ISPC)vs ›	$2.60M	N/A	N/A	N/A	N/A
Jaguar Health, Inc. (JAGX)vs ›	$2.76M	N/A	N/A	N/A	N/A
Moleculin Biotech, Inc. (MBRX)vs ›	$2.51M	N/A	N/A	N/A	N/A
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.43M	N/A	N/A	N/A	N/A
iTonic Holdings Ltd. (ITOC)vs ›	$2.38M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.32M	N/A	N/A	N/A	N/A
BioRestorative Therapies, Inc. (BRTX)vs ›	$3.18M	N/A	N/A	N/A	N/A
Adagio Medical Holdings, Inc. (ADGM)vs ›	$3.13M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.07M	N/A	10388992794.84x	12435877641.77x	12435877641.77x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics